Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins

Patients with immunodeficiencies or some types of autoimmune diseases rely on a safe therapy with intravenous immunoglobulins (IVIGs) manufactured from human plasma, the only available source for this therapeutic. Since plasma is predisposed to contamination by a variety of blood-borne pathogens, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kempf, Christoph, Stucki, Martin, Boschetti, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International Association for Biologicals. Published by Elsevier Ltd. 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129354/
https://www.ncbi.nlm.nih.gov/pubmed/16581263
http://dx.doi.org/10.1016/j.biologicals.2006.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129354/
https://www.ncbi.nlm.nih.gov/pubmed/16581263
http://dx.doi.org/10.1016/j.biologicals.2006.01.002

Ejemplares similares